Skip to content

Image - Navigated Resection of Lung Nodules

Image - Navigated Resection of Lung Nodules

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04702165
Enrollment
25
Registered
2021-01-08
Start date
2021-06-03
Completion date
2022-06-16
Last updated
2025-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Diseases

Keywords

lung nodule, lung cancer, lung mass

Brief summary

This is an open label study lung nodules that are either cancer or non-cancer and who are eligible for surgical resection. Patients will undergo their surgery with the help of the Lung Resection Marker Locator Kit which will assist the surgeon in both the location and resection of the lung nodule under real-time guidance.

Interventions

DEVICElung resection with Lung Resection Marker Locator Kit

Nodules eligible for surgical resection using the Lung Resection Marker Locator Kit

Sponsors

Navigation Sciences, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Males or females aged 21 years or older as it is extremely rare for younger people to be at risk for lung cancers. 2. Be deemed candidates for the lung resection surgery, which will be determined by their treating Thoracic Surgeon (also a physician investigator) 3. Have lesions that are nodules/GGO or other abnormal opacity that can be accurately measured in at least one dimension using conventional techniques 4. Seen at BWH Thoracic Surgery outpatient clinics or as inpatient (Note: Subjects will be formally consented to the study at BWH only)

Exclusion criteria

1. Female subjects pregnant or breastfeeding 2. Subjects with a pacemaker or equivalent devices (AICD) due to the use of electromagnetic tracking generator. 3. Patients who are not scheduled for lung surgery \-

Design outcomes

Primary

MeasureTime frameDescription
To compare the measurements from the J-bar fiducial to the first staple line obtained by the device in vivo to that performed in the frozen section room on the lung specimen obtained (which includes both the J bar and the staple line).1 daydevice feasibility

Secondary

MeasureTime frameDescription
whether coefficient is needed1 dayTo determine whether a coefficient needs to be defined to harmonize the distance measured with the device to that found by pathologists
time required for device placement1 day3\. To determine the length of time needed for the placement of the device and record measurements.
demonstrate safe surgical remove of lung nodule30 dayno increased surgical morbidity from the operation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026